Reaction

Exophthalmos reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,101 reports · 33 co-occurring drugs

As of the last recalculation, Exophthalmos appears in 2,101 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is METHIMAZOLE (PRR 43.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Methimazole3443.643.8
Bupivacaine2122.522.5
Alemtuzumab4020.920.9
Cefuroxime2118.418.4
Ketoprofen2015.215.3
Felodipine Extended-Release Tablets1513.113.2
Felodipine1513.113.1
Amitriptyline Hydrochloride2313.113.1
Nevirapine1112.112.2
Efavirenz1210.710.7
Amphotericin B1310.310.3
Tobramycin Solution108.38.3
Indomethacin118.38.3
Tobramycin Sulfate108.08.0
Zoledronic Acid317.77.8
Zidovudine107.47.4
Posaconazole Delayed-Release87.27.2
Amphetamine67.27.2
Nebivolol116.96.9
Posaconazole95.55.5
Tobramycin135.45.4
Lanreotide Acetate45.15.1
Dorzolamide Hydrochloride And Timolol Maleate45.05.0
Tenofovir Disoproxil Fumarate Tablets44.64.6
Bendamustine Hcl74.54.5
Pazopanib Hydrochloride114.04.0
Cortisone Acetate54.04.0
Travoprost33.43.4
Avapritinib43.33.3
Lifitegrast53.03.0
Daratumumab112.72.7
Onabotulinumtoxina172.22.2
Pimavanserin Tartrate61.11.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.